Initial-Use Combo Drug for BP Lowering Approved
The FDA has cleared the antihypertensive agent Avalide (irbesartan and hydrochlorothiazide) as the first combination therapy for initial use in patients who are likely to need multiple drugs to achieve their BP goals.
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.